Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Asset Writedowns and Impairment (2019 - 2021)

AVITA Medical (RCEL) has disclosed Asset Writedowns and Impairment for 1 consecutive years, with $11000.0 as the latest value for Q4 2019.

  • For the quarter ending Q4 2019, Asset Writedowns and Impairment changed N/A year-over-year to $11000.0, compared with a TTM value of $19000.0 through Dec 2023, changed N/A, and an annual FY2023 reading of $4000.0, changed N/A over the prior year.
  • Asset Writedowns and Impairment was $11000.0 for Q4 2019 at AVITA Medical, up from $8000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $11000.0 in Q4 2019 and bottomed at $8000.0 in Q3 2019.